Trial Information
Inclusion Criteria:
- Metastatic epithelial cancer
- Above 18 years of age
- Failure of at least one chemotherapy protocol
- Clinical performance status of ECOG 0,1
- Absolute neutrophil count greater than 1000/mm3
- Serum ALT/AST less than three times the upper limit of normal
- Serum creatinine less than or equal to 1.6 mg/dl.
- Must be able to understand and sign the Informed Consent document
Exclusion Criteria:
- Below 18 years of age
- Women who are pregnant
- Life expectancy of less than three months
Type of Study:
Interventional
Study Design:
N/A
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
0359-08-HMO-CTIL
NCT ID:
NCT00722228
Start Date:
Completion Date:
Related Keywords:
- Colorectal Cancer
- Ovarian Cancer
- Gastric Cancer
- Breast Cancer
- Lung Cancer
- Breast Neoplasms
- Colorectal Neoplasms
- Lung Neoplasms
- Stomach Neoplasms
- Ovarian Neoplasms